Doctor Geonwoo Park

Daejeon Wellness Hospital, Head of the Hemato-Oncology Department


TEL. 02-538-5886

FAX. 02-538-5887

E-mail. 


Academic Background

  • Yeungnam University College of Medicine, Medical Center Intern
  • Gangnam St. Mary’s Hospital, Internal Medicine Resident
  • Public Health Doctor (Gimcheon Medical Center, Affiliated
  • Hospital of Qingdao University)
  • Yeouido St. Mary’s Hospital, Seoul St. Mary’s Hospital, Oncology Clinical Instructor
  • Acquired specialization in hemato-oncology internal medicine department
  • Master of Medicine


Medical Career

  • 2011 – 2014 Daegu Fatima Hospital, Internal Medicine Manager
  • 2014 – Present  Daejeon Wellness Hospital, Head of the Oncology Department
  • The Korean Association of Internal Medicine, Full Member
  • Korean Cancer Association, Full Member
  • Korean Society of Medical Oncology, Full Member
  • Korean Cancer Study Group, Full Member
  • Korean Society for Hospice and Palliative Care, Full Member


Advisory Career

  • Apr. 2016 – June 2016  Awair Advisor
  • Jan. 2017 – Dec. 2017  IM Healthcare Advisor
  • May 2017 – Present  Blue Point Partners Medical Advisor                       
  • Apr. 2018 – Present  CytoDx Medical Director
  • Jan. 2019 – Present  DAYLI Partners Medical Advisor


Investment Experience

  • 2015  KOSDAQ Listed Company “N”
  • 2015 – 2016  Unlisted Company
    • BIOINFRA
    • Kainos Medicine
    • IM Healthcare
  • 2017  Establishment of Malaysian foreign branch (overseas medical entry)
  • 2017 – Present
    • Remedy
    • RevoSketch
    • CytoDx
    • BIORCHESTRA
    • Medibloc
    • Blue Point Partners
    • Ultra V
    • TE Bios
  • Jan. 2019  Daily Golden Time Healthcare Fund
  • Established Doctors Healthcare Investment Research Group
    • Around 400 member doctors, as well as university professors, accelerators, VCs, etc.    
    • Nov. 2017  Remedy angel investment                 
    • May 2018   MUNE (syringe disposal medical device) angel investment                 
    • July 2018   Kmedisys (arthroscope business) angel investment
    • Jan. 2019   Established private equity fund with DAYLI Partners
  • Completed Qualified Angel Investment Course


Other Activities

  • KAIST Student Venture Team Mentoring
  • Lead clinical application and research of healthcare products


Languages

  • Korean and English



OhKims Law & Company ⎪ 
CEO: Sungheon Oh, Yongbeom Kim        

Business Licence: 349-81-01238

Seoul Office: 6th floor, Seongdo Building, Dosan-daero 207, Gangnam-gu, Seoul  
Gwang-gyo Office: 208, Building A, 7-2, Gwanggyojungang-ro 248beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea 

Contact: 02-538-5886

Personal Information Manager: Joonwoo Kang

Copyright ⓒ 2017 ohkimslaw.com. All Rights Reserved.


OhKims Law & CompanyCEO: Sungheon Oh, Yongbeom Kim        

Business Licence: 349-81-01238

Seoul Office: 6th floor, Seongdo Building, Dosan-daero 207, Gangnam-gu, Seoul  
Gwang-gyo Office: 208, Building A, 7-2, Gwanggyojungang-ro 248beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea 

Contact: 02-538-5886

Personal Information Manager: Joonwoo Kang

Copyright ⓒ 2017 ohkimslaw.com. All Rights Reserved.